US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Qualigen Therapeutics Inc (QLGN)
Qualigen Therapeutics Inc (QLGN) ニュース

QLGN

Qualigen Therapeutics (QLGN)

Qualigen Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:QLGN

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/27	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/12/20	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/12/11	04 : 27	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/12/05	23 : 00	GlobeNewswire Inc.	Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/26	07 : 00	GlobeNewswire Inc.	Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/23	07 : 28	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/22	07 : 10	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/22	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/19	23 : 00	GlobeNewswire Inc.	Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/16	06 : 05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/15	06 : 25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/14	07 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/09	07 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/02	05 : 55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/11/01	22 : 00	GlobeNewswire Inc.	Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/10/30	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/10/25	06 : 06	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/10/23	05 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/10/18	05 : 05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/10/10	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/10/10	05 : 10	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/27	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/27	06 : 10	GlobeNewswire Inc.	Qualigen Therapeutics, Inc. Announces management changes.	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/21	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/20	22 : 00	GlobeNewswire Inc.	Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/10	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/07	06 : 00	GlobeNewswire Inc.	Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/07	05 : 30	GlobeNewswire Inc.	Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/07	04 : 46	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/09/05	22 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:QLGN

1 2 3 4 5 6 7 8 9 次へ >>

Health Care Select Sector

Deutsche Telekom (QX)

US Dollar vs Euro

JP Morgan Chase

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約